Research Article

A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective

Figure 1

UBE2S expression pattern in cancer and tumor tissues. (a) Divergence in UBE2S expression across cancer and normal tissues of TCGA was determined by TIMER2. (b) Divergence in UBE2S expression across cancer and corresponding para-cancerous tissues from TCGA database. . (c) Based on GEPIA online tool, pathological stage characterizations were identified by UBE2S expression in KIRP, KIRC, ACC, LIHC, KICH, BRCA, HNSC, and LUAD of TCGA. TCGA: The Cancer Genome Atlas; KIRP: kidney renal papillary cell carcinoma; KIRC: kidney renal clear cell carcinoma; ACC: adrenocortical carcinoma; LIHC: liver hepatocellular carcinoma; KICH: kidney chromophobe; BRCA: breast invasive carcinoma, HNSC: head and neck squamous cell carcinoma; LUAD: lung adenocarcinoma.
(a)
(b)
(c)